Market Research Logo

NewLink Genetics Corporation (NLNK) - Financial and Strategic SWOT Analysis Review

NewLink Genetics Corporation (NLNK) - Financial and Strategic SWOT Analysis Review

- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains crit

    ical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

NewLink Genetics Corporation (NewLink) is a biopharmaceutical company, which undertakes the discovery, development and commercialization of immunotherapeutic products for the treatment of cancer. NewLinks pipeline products include both biologic and small-molecule immune-oncology product candidates for treating various cancer indications. It utilizes its HyperAcute cellular immunotherapy technology and IDO pathway inhibitor technology to develop biologic product candidates and small-molecule product candidates, respectively. The company’s pipeline products include Algenpantucel-L, Tergenpumatucel-L, Dorgenmeltucel-L, HyperAcute Prostate, HyperAcute Renal, NLG919 and indoximod. It also develops and commercializes vaccines for the treatment of infectious diseases using its HyperAcute technology. The company has operations in the US and the UK. NewLink is headquartered in Ames, Iowa, the US.

NewLink Genetics Corporation Key Recent Developments

Apr 29, 2016: NewLink Genetics Reports First Quarter 2016 Financial Results
Feb 29, 2016: NewLink Genetics Provides Operational Update and Reports Fourth Quarter, Year End 2015 Financial Results
Feb 02, 2016: NewLink Genetics Announces Project to Develop New Treatment Options for the Zika Virus
Jan 08, 2016: NewLink Genetics Appoints Brian Wiley as Chief Commercial Officer
Nov 30, 2015: NewLink Genetics to Participate in Three Upcoming Investor Conferences

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
NewLink Genetics Corporation - Key Facts
NewLink Genetics Corporation - Key Employees
NewLink Genetics Corporation - Key Employee Biographies
NewLink Genetics Corporation - Major Products and Services
NewLink Genetics Corporation - Pharmaceutical Pipeline Products Data
NewLink Genetics Corporation, Pipeline Products by Therapy Area
NewLink Genetics Corporation, Pipeline Products by Development Phase
NewLink Genetics Corporation - History
NewLink Genetics Corporation - Company Statement
NewLink Genetics Corporation - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
NewLink Genetics Corporation - Business Description
NewLink Genetics Corporation - Corporate Strategy
NewLink Genetics Corporation - SWOT Analysis
SWOT Analysis - Overview
NewLink Genetics Corporation - Strengths
Strength - Research and Development Activities
Strength - Lead Product: Algenpantucel-L
Strength - Proprietary Patented Technology
NewLink Genetics Corporation - Weaknesses
Weakness - Lack of Commercial Products
NewLink Genetics Corporation - Opportunities
Opportunity - Strategic Initiatives
Opportunity - Orphan Drug Designation
Opportunity - Pancreatic Cancer Market
NewLink Genetics Corporation - Threats
Threat - Competitive Environment
Threat - Uncertain R&D Outcomes
Threat - Stringent Regulations
NewLink Genetics Corporation - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
NewLink Genetics Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
NewLink Genetics Corporation, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
NewLink Genetics Corporation, Recent Deals Summary
Section 5 – Company’s Recent Developments
Apr 29, 2016: NewLink Genetics Reports First Quarter 2016 Financial Results
Feb 29, 2016: NewLink Genetics Provides Operational Update and Reports Fourth Quarter, Year End 2015 Financial Results
Feb 02, 2016: NewLink Genetics Announces Project to Develop New Treatment Options for the Zika Virus
Jan 08, 2016: NewLink Genetics Appoints Brian Wiley as Chief Commercial Officer
Nov 30, 2015: NewLink Genetics to Participate in Three Upcoming Investor Conferences
Nov 13, 2015: Paolo Pucci and Nicholas Vahanian Appointed to Board of Directors of NewLink Genetics
Nov 03, 2015: NewLink Genetics Provides Operational Update and Reports Third Quarter 2015 Financial Results
Jul 31, 2015: NewLink Genetics Provides Operational Update and Reports Second Quarter 2015 Financial Results
Jul 14, 2015: NewLink Genetics Shares Immuno-Oncology Vision at Investor Day
May 05, 2015: NewLink Genetics Provides Operational Update and Reports First Quarter 2015 Financial Results
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
NewLink Genetics Corporation, Key Facts
NewLink Genetics Corporation, Key Employees
NewLink Genetics Corporation, Key Employee Biographies
NewLink Genetics Corporation, Major Products and Services
NewLink Genetics Corporation, Number of Pipeline Products by Therapy Area
NewLink Genetics Corporation, Number of Pipeline Products by Development Stage
NewLink Genetics Corporation, Pipeline Products By Therapy Area and Development Phase
NewLink Genetics Corporation, History
NewLink Genetics Corporation, Other Locations
NewLink Genetics Corporation, Subsidiaries
NewLink Genetics Corporation, Key Competitors
NewLink Genetics Corporation, Ratios based on current share price
NewLink Genetics Corporation, Annual Ratios
NewLink Genetics Corporation, Interim Ratios
NewLink Genetics Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
NewLink Genetics Corporation, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
NewLink Genetics Corporation, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
NewLink Genetics Corporation, Pipeline Products by Therapy Area
NewLink Genetics Corporation, Pipeline Products by Development Phase
NewLink Genetics Corporation, Performance Chart (2011 - 2015)
NewLink Genetics Corporation, Ratio Charts
NewLink Genetics Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
NewLink Genetics Corporation, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report